CH-EUS in Diagnosis of Inoperable Bile Duct Tumors

N/AUnknownNCT05418543

Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor40 enrolled

Overview

VALIDATION OF THE SUPERIORITY OF CONTRAST ENHANCED ENDOSCOPY TO STANDARD ENDOSCOPY IN THE DIAGNOSIS OF BILE DUCT TUMORS

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Inoperable Disease Bile Duct Cancer

Interventions

Endoscopic ultrasound with fine needle biopsyPROCEDURE

Patients with unresectable bile duct tumors will be investigated by either CH-EUS with FNA or conventional EUS with FNA

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Bile duct tumor diagnosed at endoscopic US, CT scan or MRI * INR\<1.5; platelets \> 50.000 * written consent form Exclusion Criteria: * INR\>1.5; platelets \< 50.000 * duodenal invasion or stenosis * patients denial * previous treatment for hepato-biliary tumors

Locations (1)

IRGH "O. Fodor"

Cluj-Napoca, Cluj, Romania

RECRUITING

Outcomes

Primary Outcomes

CH-EUS FNA has higher diagnostic accuracy for bile tuct tumors

To asses if CH-EUS FNB is superior to CH-EUS FNA when assessing bile duct tumors. To determine the diagnostic accuracy, sensitivity and sensibility.

Time frame: one week

Central Contacts

Rares-Ilie Orzan, PHD student

CONTACT

+40727786221 orzanrares@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.